German pharmaceutical and biotechnology company Bayer has announced plans to outsource its distribution and customer support operations for pharmaceutical products as well as marketing and sales of over-the-counter medicines to a third party in what will affect some of its employees.
The giant pharmaceutical says the move, which takes effect in May, is aimed at ‘simplifying its value chain’ and reducing the lead time between production and distribution.
